UNAIDS estimated that there were some 630,000 people worldwide that died from acquired immune deficiency syndrome (AIDS) in 2023. This statistic depicts the total number of annual AIDS-related deaths worldwide from 2000 to 2023. HIV/AIDS burden A majority of countries with the highest burden due to HIV and AIDS are in Africa- in 2023, the highest number of AIDS-related deaths occurred in South Africa and Nigeria and the highest prevalence of HIV was found in Eswatini. Although access to life-saving antiretroviral therapy treatment (ART) has increased globally over recent years, many individuals living with HIV still lack access to ART. Barriers and interventions In part due to the development of ART, the number of people living with HIV worldwide is continuing to increase, reaching almost 40 million in 2023. Important public health measures to combat the burden of the disease include a combination of biomedical and behavioral interventions such as pre- and post-exposure prophylaxis, and context-specific structural interventions to reduce barriers to supplies and education. One prominent barrier faced by those living with HIV is stigma, which can often cause disadvantages in many areas of life, including employment, use of health services, and social support.

HIV/AIDS deaths in the U.S. have dropped significantly in recent years. In 1995, the death rate from HIV per 100,000 people was 16.2. That number has since decreased to 1.3 per 100,000 as of 2023. The reduction in the HIV death rate in the U.S. can be attributed to an increase in access to HIV medications. HIV/AIDS in the U.S. Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) cause a systemic viral infection that damages the immune system. AIDS is a syndrome that is caused by HIV. AIDS is when the immune system is severely weakened by HIV and the body can no longer fight off infections. Among all U.S. states, Georgia, followed by Florida and Louisiana, had the highest rates of new HIV diagnoses in 2022. HIV/AIDS treatments in the U.S. HIV/AIDS treatments include antiretroviral medications to reduce the levels of HIV within the body. The largest funders for HIV/AIDS medications and research are the National Institutes of Health (NIH) and the Ryan White Program. The top HIV drug worldwide, based on revenue generated in 2023 was Biktarvy. Around the world, access to antiretroviral treatment has increased dramatically in recent years, a huge step in reducing the number of HIV-related deaths. There is currently no cure for HIV.

In 2023, South Africa and Nigeria had the highest number of deaths due to AIDS worldwide, with around ** thousand and ** thousand such deaths, respectively. African countries account for eight of the top 10 countries with the highest number of AIDS-related deaths worldwide. AIDS-related deaths worldwide have been gradually declining over the past decade, decreasing from *** million deaths in 2010 to *** thousand deaths in 2023. HIV/AIDS HIV (human immunodeficiency virus) is an infectious sexually transmitted disease that is transmitted via exposure to infected semen, blood, vaginal and anal fluids and breast milk. HIV weakens the human immune system, resulting in the affected person being unable to fight off opportunistic infections. The top 15 countries worldwide with the highest prevalence of new HIV infections as of 2023 were all African. HIV treatment Although there is currently no effective cure for HIV, death can be prevented by taking HIV antiretroviral therapy (ART). Access to antiretroviral therapy worldwide has significantly increased in the past decade. As of 2023, around **** million people with HIV worldwide were receiving ART. The leading countries with the highest percentage of HIV-infected children who were receiving ART were Eswatini, Kenya, and Lesotho.

This dataset contains death counts, crude rates and adjusted rates for selected causes of death by county and region. For more information, check out: http://www.health.ny.gov/statistics/vital_statistics/, or go to the "About" tab.

This is an extract of Causes of death since 1997 to 2012 for HIV /Aids which includes B20, B21, B22, B23, B24 (according with the ICD-10 code).

This data set includes tables on persons living with HIV/AIDS, newly diagnosed HIV cases and all cause deaths in HIV/AIDS cases by gender, age, race/ethnicity and transmission category. In all tables, cases are reported as of December 31 of the given year, as reported by January 9, 2019, to allow a minimum of 12 months reporting delay. Gender is determined by both current gender and sex at birth variables; transgender values are assigned when current gender is identified as "Transgender" or when a discrepancy is identified between a person's sex at birth and their current gender (e.g., cases where sex at birth is "Male" and current gender is "Female" will become Transgender: Male to Female.) Prior to 2003, Asian and Native Hawaiian/Pacific Islanders were classified as one combined group. In order to present these race/ethnicities separately, living cases recorded under this combined classification were split and redistributed according to their expected proportional population representation estimated from post-2003 data.

This dataset contains death counts and crude rates by region, age group, and selected cause of death. For more information, check out: http://www.health.ny.gov/statistics/vital_statistics/, or go to the "About" tab.

AIDS estimated deaths (UNAIDS estimates) in Namibia was reported at 3100 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Namibia - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

AIDS estimated deaths (UNAIDS estimates) in Guyana was reported at 200 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Guyana - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

In 2019, Estimated AIDS Deaths in Indonesia grew 5.3% compared to a year earlier.

AIDS estimated deaths (UNAIDS estimates) in Guatemala was reported at 500 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Guatemala - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on May of 2025.

AIDS estimated deaths (UNAIDS estimates) in Morocco was reported at 500 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Morocco - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

Forecast: Estimated AIDS Deaths in France 2022 - 2026 Discover more data with ReportLinker!

The AIDS Public Information Data Set (APIDS) for years 1981-2002 on CDC WONDER online database contains counts of AIDS (Acquired Immune Deficiency Syndrome) cases reported by state and local health departments, by demographics; location (region and selected metropolitan areas); case-definition; month/year and quarter-year of diagnosis, report, and death (if applicable); and HIV exposure group (risk factors for AIDS). Data are produced by the US Department of Health and Human Services (US DHHS), Public Health Service (PHS), Centers for Disease Control and Prevention (CDC), National Center for HIV, STD and TB Prevention (NCHSTP), Division of HIV/AIDS Prevention (DHP).

AIDS estimated deaths (UNAIDS estimates) in Costa Rica was reported at 200 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Costa Rica - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

In 2023, more females than males died from HIV or AIDS in both African regions displayed, with 10,000 more deaths among women and girls in the East and Southern Africa region. This statistic shows the number of deaths from HIV/AIDS in Africa in 2023, by region and gender.

Forecast: Estimated AIDS Deaths in Brazil 2022 - 2026 Discover more data with ReportLinker!

AIDS estimated deaths (UNAIDS estimates) in Myanmar was reported at 6400 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Myanmar - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on June of 2025.

BackgroundSince the first HIV/AIDS case appeared in 1980s, HIV/AIDS has been the focus of international attention. As a major public health problem, there are epidemiological uncertainties about the future of HIV/AIDS. It is important to monitor the global statistics of HIV/AIDS prevalence, deaths, disability adjusted life years (DALYs), and risk factors for adequate prevention and control.MethodsThe Global Burden of Disease Study 2019 database was used to analyze the burden of HIV/AIDS in 1990–2019. By extracting global, regional, and national data on HIV/AIDS prevalence, deaths, and DALYs, we described the distribution by age and sex, explored the risk factors, and analyzed the trends in HIV/AIDS.ResultsIn 2019, there were 36.85 million HIV/AIDS cases (95% UI: 35.15–38.86 million), 863.84 thousand deaths (95% UI: 78.61–99.60 thousand), and 47.63 million (95% UI: 42.63–55.65 million) DALYs. The global age-standardized HIV/AIDS prevalence, death, and DALY rates were 454.32 (95% UI: 433.76–478.59), 10.72 (95% UI: 9.70–12.39), and 601.49 (95% UI: 536.16–703.92) per 100,000 cases, respectively. In 2019, the global age-standardized HIV/AIDS prevalence, death, and DALY rates increased by 307.26 (95% UI: 304.45–312.63), 4.34 (95% UI: 3.78–4.90), and 221.91 (95% UI: 204.36–239.47) per 100,000 cases, respectively, compared to 1990. Age-standardized prevalence, death, and DALY rates decreased in high sociodemographic index (SDI) areas. High age-standardized rates were observed in low sociodemographic index areas, while low age-standardized rates were observed in high sociodemographic index areas. In 2019, the high age-standardized prevalence, death, and DALY rates were predominant in Southern Sub-Saharan Africa, and global DALYs peaked in 2004 and subsequently decreased. The highest global HIV/AIDS DALYs were in the 40–44 age group. The main risk factors affecting HIV/AIDS DALY rates included behavioral risks, drug use, partner violence, and unsafe sex.ConclusionsHIV/AIDS disease burden and risk factors vary by region, sex, and age. As access to health care increases across countries and treatment for HIV/AIDS infection improves, the HIV/AIDS disease burden is concentrated in areas with low SDIs, particularly in South Africa. Regional differences should be fully considered to target optimal prevention strategies and treatment options based on risk factors.